CASI Pharmaceuticals, Inc.

Q4 2024 13F Holders

Symbol
CASIF
CUSIP
G1933S101
Type
Equity
Class
ORD SHS
Num filers
23
Total reported value, excl. options
$7.52M
Manager Report Date Value ($000) Shares Option Type